BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9458859)

  • 1. Platelet-derived lysophosphatidic acid decreases endothelial permeability in vitro.
    Alexander JS; Patton WF; Christman BW; Cuiper LL; Haselton FR
    Am J Physiol; 1998 Jan; 274(1):H115-22. PubMed ID: 9458859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet lipid(s) bound to albumin increases endothelial electrical resistance: mimicked by LPA.
    Minnear FL; Patil S; Bell D; Gainor JP; Morton CA
    Am J Physiol Lung Cell Mol Physiol; 2001 Dec; 281(6):L1337-44. PubMed ID: 11704528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein, not adenosine or adenine nucleotides, mediates platelet decrease in endothelial permeability.
    Patil S; Kaplan JE; Minnear FL
    Am J Physiol; 1997 Nov; 273(5):H2304-11. PubMed ID: 9374767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets and a platelet-released factor enhance endothelial barrier.
    Haselton FR; Alexander JS
    Am J Physiol; 1992 Dec; 263(6 Pt 1):L670-8. PubMed ID: 1476205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of adenosine in platelet-mediated reduction in pulmonary vascular permeability.
    Paty PS; Sherman PF; Shepard JM; Malik AB; Kaplan JE
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H771-7. PubMed ID: 1558187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood.
    Sano T; Baker D; Virag T; Wada A; Yatomi Y; Kobayashi T; Igarashi Y; Tigyi G
    J Biol Chem; 2002 Jun; 277(24):21197-206. PubMed ID: 11929870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets decrease albumin permeability of pulmonary artery endothelial cell monolayers.
    Shepard JM; Moon DG; Sherman PF; Weston LK; Del Vecchio PJ; Minnear FL; Malik AB; Kaplan JE
    Microvasc Res; 1989 May; 37(3):256-66. PubMed ID: 2733598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrolysis of phosphatidylserine-exposing red blood cells by secretory phospholipase A2 generates lysophosphatidic acid and results in vascular dysfunction.
    Neidlinger NA; Larkin SK; Bhagat A; Victorino GP; Kuypers FA
    J Biol Chem; 2006 Jan; 281(2):775-81. PubMed ID: 16278219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
    Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
    Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane sidedness of biosynthetic pathways involved in the production of lysophosphatidic acid.
    le Balle F; Simon MF; Meijer S; Fourcade O; Chap H
    Adv Enzyme Regul; 1999; 39():275-84. PubMed ID: 10470378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic acid activates nuclear factor kappa B and induces proinflammatory gene expression in endothelial cells.
    Palmetshofer A; Robson SC; Nehls V
    Thromb Haemost; 1999 Nov; 82(5):1532-7. PubMed ID: 10595650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPA
    Dancs PT; Ruisanchez É; Balogh A; Panta CR; Miklós Z; Nüsing RM; Aoki J; Chun J; Offermanns S; Tigyi G; Benyó Z
    FASEB J; 2017 Apr; 31(4):1547-1555. PubMed ID: 28069828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis.
    English D; Kovala AT; Welch Z; Harvey KA; Siddiqui RA; Brindley DN; Garcia JG
    J Hematother Stem Cell Res; 1999 Dec; 8(6):627-34. PubMed ID: 10645770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide and cGMP regulate endothelial permeability and F-actin distribution in hydrogen peroxide-treated endothelial cells.
    Liu SM; Sundqvist T
    Exp Cell Res; 1997 Aug; 235(1):238-44. PubMed ID: 9281373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lysophosphatidic acid is produced through diverse phospholipase pathways.
    Aoki J; Taira A; Takanezawa Y; Kishi Y; Hama K; Kishimoto T; Mizuno K; Saku K; Taguchi R; Arai H
    J Biol Chem; 2002 Dec; 277(50):48737-44. PubMed ID: 12354767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets attenuate oxidant-induced permeability in endothelial monolayers: glutathione-dependent mechanisms.
    Strange C; Gottehrer A; Birmingham K; Heffner JE
    J Appl Physiol (1985); 1996 Oct; 81(4):1701-6. PubMed ID: 8904589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions.
    Siess W; Zangl KJ; Essler M; Bauer M; Brandl R; Corrinth C; Bittman R; Tigyi G; Aepfelbacher M
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6931-6. PubMed ID: 10359816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2.
    Panetti TS; Chen H; Misenheimer TM; Getzler SB; Mosher DF
    J Lab Clin Med; 1997 Feb; 129(2):208-16. PubMed ID: 9016857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of ionomycin-induced endothelial cell barrier dysfunction.
    Garcia JG; Schaphorst KL; Shi S; Verin AD; Hart CM; Callahan KS; Patterson CE
    Am J Physiol; 1997 Jul; 273(1 Pt 1):L172-84. PubMed ID: 9252554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine decreases permeability of in vitro endothelial monolayers.
    Haselton FR; Alexander JS; Mueller SN
    J Appl Physiol (1985); 1993 Apr; 74(4):1581-90. PubMed ID: 7685754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.